Vestcor Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Vestcor Inc’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-82,719	Closed	-$15.2M	–	1377
2021 Q2	$15.2M	Sell	82,719 -389	-0.5%	-$66.8K	0.51%	44
2021 Q1	$12.7M	Buy	83,108 +20,964	+34%	+$3.24M	0.48%	44
2020 Q4	$9.71M	Buy	62,144 +49,390	+387%	+$6.35M	0.4%	70
2020 Q3	$1.46M	Sell	12,754 -55	-0.4%	-$5.93K	0.07%	302
2020 Q2	$1.44M	Buy	12,809 +8,071	+170%	+$857K	0.07%	265
2020 Q1	$425K	Buy	4,738 +900	+23%	+$88.3K	0.02%	438
2019 Q4	$415K	Buy	+3,838	New	+$410K	0.02%	523

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Vestcor Inc's ALXN Position: Q3 2021 in Review

Vestcor Inc sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 82,719 shares — an estimated $15.2M sold.

Vestcor Inc first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $15.2M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Vestcor Inc reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Vestcor Inc sold 82,719 Alexion Pharmaceuticals shares in Q3 2021, an estimated $15.2M.
Vestcor Inc first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
Vestcor Inc's Alexion Pharmaceuticals position peaked at $15.2M in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Vestcor Inc's 13F filing for Q3 2021, filed 15 Nov 2021.